Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Z-338 (acotiamide) Phase III trial in paediatric functional dyspepsia
jRCT2080225344Phase 3Completed
- Sponsor
- Zeria Pharmaceutical Co., Ltd.
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in functional dyspepsia (FD) comparing Acotiamide with Placebo (2 arms). Primary endpoints: Pharmacokinetics of acotiamide in paediatric patients, Efficacy of acotiamide on functional dyspepsia symptoms and 1 more. Started Aug 2020; status: completed.
02
Drugs
acotiamide
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on jRCT2080225344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225344.